Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia
β Scribed by Soheil Meshinchi; Franklin O. Smith; Robert J. Arceci
- Book ID
- 107546197
- Publisher
- Current Science Inc.
- Year
- 2003
- Tongue
- English
- Weight
- 415 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1523-3790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Significantly elevated telomerase activity (TA) has been found in samples from patients with almost all malignant hematologic diseases. The impact of elevated TA on the course of pediatric patients with acute myeloid leukemia (PβAML) is unknown. ## METHODS Using a modif
34 patients with acute promyelocytic leukemia (APL) were treated with daunorubicin (DNR) alone and simultaneous supportive therapy with low-dose heparin, platelet transfusions, and fresh frozen plasma. Two consecutive maintenance therapy regimens were employed in patients who achieved complete remis